PURE Bioscience (PURE)
(Delayed Data from OTC)
$0.10 USD
+0.02 (25.81%)
Updated May 28, 2024 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
PURE Bioscience [PURE]
Reports for Purchase
Showing records 21 - 40 ( 47 total )
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G
Company: PURE Bioscience
Industry: Medical - Products
C. K. COOPER HEALTHCARE DROPPING COVERAGE
Provider: C.K. Cooper and Company
Company: PURE Bioscience
Industry: Medical - Products
Griffin Securities Suspends Coverage of PURE Bioscience
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G
Company: PURE Bioscience
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: ZENG G